Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate |
2007-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2010508275-A |
titleOfInvention |
Method of hormonal treatment utilizing dose escalation long-term cycle therapy program |
abstract |
The present invention provides a dose escalation long-term cycle treatment program in which estrogen and progestin are administered to a woman for a period of more than 30 consecutive days or 31 days, optionally followed by a period of non-hormone administration or estrogen administration To do. The disclosed treatment program can be administered to women to provide contraceptive and non-contraceptive benefits. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019524846-A |
priorityDate |
2006-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |